Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Bukreyev

Showing results (1-10 of 169) with videos related to

Pageof 17
Sort By:
The Lancet. Infectious Diseases|June 27, 2021
Antibody responses to filovirus infections in humans: protective or not?Philipp A Ilinykh, Alexander Bukreyev
STAR Protocols|October 6, 2024
Protocol for quantification of intercellular connection transmission in ebolavirus infections using ImageJRodrigo I Santos, Alexander Bukreyev
Expert Review of Vaccines|August 7, 2003
Expression of immunomodulating molecules by recombinant viruses: can the immunogenicity of live virus vaccines be improved?Alexander Bukreyev, Igor M Belyakov
Current Opinion in Molecular Therapeutics|January 30, 2008
Newcastle disease virus as a vaccine vector for humansAlexander Bukreyev, Peter L Collins
Journal of Virology|July 28, 2012
The secreted G protein of human respiratory syncytial virus antagonizes antibody-mediated restriction of replication involving macrophages and complementAlexander Bukreyev, Lijuan Yang, Peter L Collins
Trends in Microbiology|September 12, 2018
Can Ebola Virus Vaccines Have Universal Immune Correlates of protection?Michelle Meyer, Delphine C Malherbe, Alexander Bukreyev
The Journal of Infectious Diseases|September 1, 2023
Interplay of Ebola Virus With Immune Cells Leading to Their Death by Diverse MechanismsMathieu Iampietro, Lucia Amurri, Olivier Reynard, et al.
The Journal of Infectious Diseases|August 8, 2018
Ebola Virus Shed Glycoprotein Triggers Differentiation, Infection, and Death of Monocytes Through Toll-Like Receptor 4 ActivationMathieu Iampietro, Rodrigo I Santos, Ndongala Michel Lubaki, et al.
Mbio|April 27, 2017
The Toll-Like Receptor 4 Antagonist Eritoran Protects Mice from Lethal Filovirus ChallengePatrick Younan, Palaniappan Ramanathan, Jessica Graber, et al.
Frontiers in Virology (Lausanne, Switzerland)|October 14, 2022
Effects of Overexpression of the Egyptian Fruit Bat Innate Immune Genes on Filovirus Infections in the Host CellsIvan V Kuzmin, Palaniappan Ramanathan, Christopher F Basler, et al.
Pageof 17

Showing results (1-10 of 169) with videos related to

Sort By:
Pageof 17
The Lancet. Infectious Diseases|June 27, 2021
Antibody responses to filovirus infections in humans: protective or not?Philipp A Ilinykh, Alexander Bukreyev
STAR Protocols|October 6, 2024
Protocol for quantification of intercellular connection transmission in ebolavirus infections using ImageJRodrigo I Santos, Alexander Bukreyev
Expert Review of Vaccines|August 7, 2003
Expression of immunomodulating molecules by recombinant viruses: can the immunogenicity of live virus vaccines be improved?Alexander Bukreyev, Igor M Belyakov
Current Opinion in Molecular Therapeutics|January 30, 2008
Newcastle disease virus as a vaccine vector for humansAlexander Bukreyev, Peter L Collins
Journal of Virology|July 28, 2012
The secreted G protein of human respiratory syncytial virus antagonizes antibody-mediated restriction of replication involving macrophages and complementAlexander Bukreyev, Lijuan Yang, Peter L Collins
Trends in Microbiology|September 12, 2018
Can Ebola Virus Vaccines Have Universal Immune Correlates of protection?Michelle Meyer, Delphine C Malherbe, Alexander Bukreyev
The Journal of Infectious Diseases|September 1, 2023
Interplay of Ebola Virus With Immune Cells Leading to Their Death by Diverse MechanismsMathieu Iampietro, Lucia Amurri, Olivier Reynard, et al.
The Journal of Infectious Diseases|August 8, 2018
Ebola Virus Shed Glycoprotein Triggers Differentiation, Infection, and Death of Monocytes Through Toll-Like Receptor 4 ActivationMathieu Iampietro, Rodrigo I Santos, Ndongala Michel Lubaki, et al.
Mbio|April 27, 2017
The Toll-Like Receptor 4 Antagonist Eritoran Protects Mice from Lethal Filovirus ChallengePatrick Younan, Palaniappan Ramanathan, Jessica Graber, et al.
Frontiers in Virology (Lausanne, Switzerland)|October 14, 2022
Effects of Overexpression of the Egyptian Fruit Bat Innate Immune Genes on Filovirus Infections in the Host CellsIvan V Kuzmin, Palaniappan Ramanathan, Christopher F Basler, et al.
Pageof 17